1. Prognostic implication of NOTCH1 in early stage oral squamous cell cancer with occult metastases
    Shan Wang et al, 2018, Clinical Oral Investigations CrossRef
  2. Cancer Stem Cells in Melanoma
    Ainara Soria et al, 2014, Stem Cells in Cancer: Should We Believe or Not? CrossRef
  3. CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition
    Cynthia M. Simbulan-Rosenthal et al, 2019, Journal of Oncology CrossRef
  4. Novel Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy to Eradicate Both Differentiated Cancer Cells and Cancer-Initiating Cells in Solid Tumors
    Francesco Sabbatino et al, 2014, Seminars in Oncology CrossRef
  5. SOX10 Ablation Arrests Cell Cycle, Induces Senescence, and Suppresses Melanomagenesis
    Julia C. Cronin et al, 2013, Cancer Research CrossRef
  6. In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells
    Florencia Paula Madorsky Rowdo et al, 2017, Oncology Reports CrossRef
  7. 3D matrix promotes cell dedifferentiation into colorectal cancer stem cells via integrin/cytoskeleton/glycolysis signaling
    Tong Han et al, 2022, Cancer Science CrossRef
  8. Monoclonal antibodies targeting non-small cell lung cancer stem-like cells by multipotent cancer stem cell monoclonal antibody library
    Kaiyue Cao et al, 2017, International Journal of Oncology CrossRef
  9. CD133 Antigen as a Potential Marker of Melanoma Stem Cells: In Vitro and In Vivo Studies
    Tomasz Kloskowski et al, 2020, Stem Cells International CrossRef
  10. Angiogenic gene characterization and vessel permeability of dermal microvascular endothelial cells isolated from burn hypertrophic scar
    Esteban A. Molina et al, 2022, Scientific Reports CrossRef
  11. Primary impact of Gli1 on radioresistance in esophageal cancer
    Fei Yao et al, 2019, Oncology Letters CrossRef
  12. Curcumin enhances the effectiveness of cisplatin by suppressing CD133+ cancer stem cells in laryngeal carcinoma treatment
    HEJIA ZHANG et al, 2013, Experimental and Therapeutic Medicine CrossRef
  13. Isolation of Melanoma Cell Subpopulations Using Negative Selection
    Ana Slipicevic et al, 2014, Molecular Diagnostics for Melanoma CrossRef
  14. CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis
    null Simbulan-Rosenthal et al, 2019, Cancers CrossRef
  15. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells
    Motahareh Rajabi Fomeshi et al, 2015, Cellular and Molecular Biology Letters CrossRef
  16. Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells
    Cynthia M. Simbulan-Rosenthal et al, 2022, International Journal of Molecular Sciences CrossRef
  17. Expression of CD133 Cancer Stem Cell Marker in Melanoma: A Systematic Review and Meta-Analysis
    Zahra Madjd et al, 2016, The International Journal of Biological Markers CrossRef
  18. Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis
    MarĂ­a Contador-Troca et al, 2015, Molecular Cancer CrossRef
  19. Intratumor and Intertumor Heterogeneity in Melanoma
    Tomasz M. Grzywa et al, 2017, Translational Oncology CrossRef